about
A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to DiseaseViscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approachTissue factor levels in type 2 diabetes mellitus.Atypical erythrocytes and platelets in a patient with a pro-thrombin mutation.The dormant blood microbiome in chronic, inflammatory diseases.Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnosticsA Comprehensive Review on Eryptosis.Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Oxidation inhibits iron-induced blood coagulation.Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharideThe effect of physiological levels of South African puff adder (Bitis arietans) snake venom on blood cells: an in vitro modelHigh ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Novel Diagnostic and Monitoring Tools in Stroke: an Individualized Patient-Centered Precision Medicine Approach.Erythrocytes and their role as health indicator: Using structure in a patient-orientated precision medicine approach.Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice.Transient ischemic attack during smoking: The thrombotic state of erythrocytes and platelets illustrated visually.Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease.Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes.The effect of iron overload on red blood cell morphology.Interleukin-12 and its procoagulant effect on erythrocytes, platelets and fibrin(ogen): the lesser known side of inflammation.Novel use of scanning electron microscopy for detection of iron-induced morphological changes in human blood.The inflammatory effects of TNF-α and complement component 3 on coagulation.Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8.Eryptosis in Haemochromatosis: Implications for rheology.Hemorheological mechanisms for increased thrombosis in subjects using gestodeneThe Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type DementiaThe Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes
P50
Q29248210-7DDAFB2B-BA5B-42D2-96BD-4E7F83B1F771Q30390876-71BE2202-E1F0-4EDE-A57C-700AAF49292DQ30399242-D47DDADF-22F0-45F1-BE61-6B81A04C0298Q34336207-7F13F66E-AC12-47D5-A5BF-51AECFFC976DQ34474989-460C4E24-3D8D-42D6-8812-4A3CA17559CEQ35189544-4C1E5FA7-38B9-4FDB-89DA-D05F73ABB462Q36172380-CE43A9D1-C74C-42DC-B25D-DD3F9272917EQ36546334-EC8D7E1A-13C0-4FB9-BC4F-55D597CB0EB8Q36634243-717B1DB2-0896-4CFF-9E88-D24767E4B3E9Q37209089-4ADEEE9A-C322-433E-8DAE-4F8F91B376F8Q37304424-A07DD2BF-1004-4519-97B9-7D8FFE4425E9Q37360390-7D297C83-B256-4C6D-BBDD-210BC25F749FQ37369954-88BDD8FF-2599-4444-94F7-56296C883C08Q37458594-CA9CCCB0-88EE-49C4-AB92-BA97C6648E59Q38674418-E15BDB11-03D3-43F4-829F-18719D7BD492Q38734258-15106F4A-B3E5-46F9-9BB6-EF4A6B7379CDQ38834350-78444108-93C1-4E56-8FB1-AC82502B3BDDQ38929421-1AEB84DE-2779-4CC0-B483-C1B31B90860DQ39064763-6DE14E94-7AEB-4D05-8E85-A0277490D70DQ45876275-0843F539-42F9-4601-8B43-1A9415B0468CQ46186707-B6E6721F-4513-4C10-AE82-A2A46ABF5618Q46876072-272FE314-954C-476A-B32A-33F540DDF156Q46936681-019928E1-81FB-4011-9294-0BCAAA6BA474Q48147174-714AE5CC-4235-482C-B8F1-8A2A2EF7F88DQ50066777-3F6EDF78-49EA-4234-B8F6-B79751A92B74Q53687856-23F21CE6-4911-45F5-9EF0-C08AFCA425E9Q58546820-B50399C3-CDD5-4512-AB90-1E3C3669EB19Q58719165-E13D46B4-5990-44D0-A096-7755A596A97CQ90770609-271FAAAE-A530-4BC6-8A27-250B023E1FBB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Janette Bester
@en
Janette Bester
@nl
type
label
Janette Bester
@en
Janette Bester
@nl
prefLabel
Janette Bester
@en
Janette Bester
@nl
P31
P496
0000-0002-8931-9194